Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Peficitinib | ASP-015K; JNJ-54781532 | Approved | Astellas Pharma Inc | Smyraf | Japan | Arthritis, Rheumatoid | Astellas Pharma Inc | 2019-03-29 | Arthritis, Rheumatoid | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
ABBV-712 | ABBV-712 | Phase 1 Clinical | Abbvie Inc | Psoriasis | Details |
ICP-332 | ICP-332 | Phase 1 Clinical | InnoCare Pharma Ltd | Psoriasis; Dermatitis, Atopic | Details |
ESK-001 | ESK-001 | Phase 1 Clinical | Alumis Inc | Autoimmune Diseases; Psoriasis | Details |
TQ-05105 | TQ-05105 | Phase 2 Clinical | Lianyungang Runzhong Pharmaceutical Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Centaurus Biopharma Co Ltd | Neoplasms; Graft vs Host Disease; Myeloproliferative Disorders; Primary Myelofibrosis; Lymphohistiocytosis, Hemophagocytic | Details |
NDI-034858 | NDI-034858 | Phase 2 Clinical | Nimbus Therapeutics | Plaque psoriasis | Details |
MAX-40070 | MAX-40070 | Phase 1 Clinical | Maxinovel Pty Ltd | Alopecia Areata | Details |
TLL-018 | TLL-018 | Phase 2 Clinical | Tll Pharmaceutical | Arthritis, Rheumatoid; Chronic Urticaria; Psoriasis; Urticaria | Details |
Ropsacitinib | PF-06826647 | Pfizer Pharmaceuticals Ltd (China) | Details | ||
GLPG-3667 | GLPG-3667 | Galapagos Nv | Details | ||
Brepocitinib | PF-06700841-15; PF-6700841; PF-841; PF-06700841 | Phase 3 Clinical | Pfizer Inc | Alopecia; Alopecia Areata; Dermatomyositis; Lupus Erythematosus, Systemic; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Dermatitis, Atopic; Vitiligo; Crohn Disease | Details |
GLPG-3121 | GLPG-3121 | Phase 1 Clinical | Galapagos Nv | Details | |
OST-122 | OST-122 | Phase 2 Clinical | Oncostellae | Colitis, Ulcerative | Details |
BGB-23339 | BGB-23339 | Phase 1 Clinical | Beigene Ltd | Autoimmune Diseases; Plaque psoriasis | Details |
ICP-488 | ICP-488 | Phase 1 Clinical | InnoCare Pharma Ltd | Autoimmune Diseases; Psoriasis; Plaque psoriasis | Details |
This web search service is supported by Google Inc.